“I don’t want to lose my wife.”Patients with pulmonary arterial hypertension (PAH) and their families are urging the ...

As the government moves to formally introduce medication abortion, a National Assembly research body has called for drug ...

Emocog has signed a three-year agreement granting Daewoong Pharmaceutical exclusive sales, marketing and commercialization ...

GC Wellbeing has joined forces with Boryung to expand Laennec Injection’s reach beyond primary care and into the hospital ...

Celltrion said Tuesday that it renewed European Union Good Manufacturing Practice (EU-GMP) certification for its drug ...

Pfizer has detailed its phase 3 strategy for testing berobenatide in obstructive sleep apnea (OSA), with a newly registered ...

Cancer survivors may assume that once their disease has been successfully treated, they are unlikely to develop another cancer.In fact, cancer survivors face a higher risk of developing a new, unrelat ...

Korea participates in about 60 percent of Gilead Sciences’ global oncology clinical trials, the company’s Korean affiliate ...

Reports of adverse events associated with growth hormone products have steadily increased over the past five years in Korea, rising from 1,189 cases in 2021 to 1,910 in 2025. Another 823 cases were re ...

Korean researchers have found that neuropsychiatric symptoms in Alzheimer’s disease, including delusions, anxiety and apathy, are associated with specific pathological protein accumulations in the bra ...

Korea University Medicine (KUM) is expanding cooperation with major U.S. medical innovation institutions to help Korean biotech and medical technology companies enter the U.S. market, connecting them ...

Korea will ease eligibility requirements for cadaver dissection by eliminating a rule requiring specialists to have worked full-time at a general hospital for at least five years.Under the revised rul ...